IP82-17: Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie’s Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study

IP82-17: Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie’s Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study

Monday, May 18, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)

146C

Abstract

Speakers

Sessions

IP82: Sexual Function/Dysfunction: Peyronie’s Disease

Monday, May 18, 2026 9:30 AM to 11:30 AM

Amy Guise · Medical College of Wisconsin

Alan Shindel · UCSF

Faysal Yafi · University of California, Irvine (UCI)

Log in

See all the content and easy-to-use features by logging in or registering!